1. Poly-Agonist Pharmacotherapies for Metabolic Diseases: Hopes and New Challenges

   • Camille Allard
   • Daniela Cota
   • Carmelo Quarta

   Review Article 21 December 2023 Pages: 127 - 148

   

2. A Neuroanatomic and Pathophysiologic Framework for Novel Pharmacological Approaches to the Treatment of Post-traumatic Stress Disorder

   • Michael A. Norred
   • Zachary D. Zuschlag
   • Mark B. Hamner

   Review Article 28 February 2024 Pages: 149 - 164

   

3. Long-Term Efficacy and Tolerability of PCSK9 Targeted Therapy: A Review of the Literature

   • Willemijn A. M. Schonck
   • Erik S. G. Stroes
   • Laurens F. Reeskamp

   Review Article Open access 25 January 2024 Pages: 165 - 178

   

4. Chinese Herbal Medicines for Coronary Heart Disease: Clinical Evidence, Pharmacological Mechanisms, and the Interaction with Gut Microbiota

   • Linhai Cao
   • Hongxia Ni
   • Hui Chang

   Review Article 24 January 2024 Pages: 179 - 202

   

5. Methadone for Cancer Pain Management in Children: A Review of Literature

   • Sebastiano Mercadante

   Review Article 07 February 2024 Pages: 203 - 208

6. Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry

   • Jonathan Schimmel
   • Lindsey Claire Epperson
   • the Toxicology Investigators Consortium FACT Study Group

   Original Research Article 10 January 2024 Pages: 209 - 217

   

7. Lumasiran: A Review in Primary Hyperoxaluria Type 1

   • Connie Kang

   Adis Drug Evaluation Open access 22 January 2024 Pages: 219 - 226

8. Tirzepatide: A Review in Type 2 Diabetes

   • Nicole L. France
   • Yahiya Y. Syed

   Adis Drug Evaluation 23 February 2024 Pages: 227 - 238

   

9. Repotrectinib: First Approval

   • Sohita Dhillon

   AdisInsight Report 27 January 2024 Pages: 239 - 246

   

10. Etrasimod: First Approval

    • Matt Shirley

    AdisInsight Report 23 February 2024 Pages: 247 - 254

    

11. Correction to: Nedosiran: First Approval

    • Yahiya Y. Syed

    Correction Open access 22 January 2024 Pages: 255 - 255